Clinical Trials Browser

Phase 2/3 × Peripheral Blood Stem Cell Transplantation × Clear all

NCT00630565 2024-01-29

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Phase 2/3 Terminated

12 enrolled 12 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia

NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Phase 2/3 Completed

Hodgkin Disease, Lymphoma, Recurrence